Winning the Battle, Losing the War: The Noncurative “Curative” Resection for Stage I Adenocarcinoma of the Lung

Stage I adenocarcinoma of the lung recurs. Identifying high-risk patients will simplify decision making for adjuvant therapy and surveillance. Thorough mediastinal lymphadenectomy dissociates tumor size as a predictor of survival and may itself provide an important survival benefit.